Medpace Holdings MEDP
NASDAQ MEDP
$611.39 -7.66 (-1.24%)
As of: Aug 27, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Total Current Liabilities came in at $1.4 billion in Q2 2026, up 17.62% YoY from $1.2 billion in Q2 2025, and up 6.72% on a QoQ basis from $1.3 billion in Q1 2026.

Medpace Holdings (MEDP) Total Current Liabilities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has 12 years of Total Current Liabilities data on file, last reported at $1.4 billion in Q2 2026.

  • Quarterly Total Current Liabilities rose 17.62% year-over-year to $1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.4 billion (up 17.62% YoY) and the FY2025 annual result came in at $1.3 billion, up 21.66% from the prior year.
  • Total Current Liabilities improved to $1.4 billion in Q2 2026, from $1.3 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $1.4 billion in Q2 2026 to a low of $579.4 million in Q1 2022.
  • A 5-year average of $1.0 billion and a median of $974.9 million in 2024 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Current Liabilities jumped 85.98% — and 2023, when it dropped 3.02%.
  • Tracing MEDP's Total Current Liabilities over 5 years: stood at $803.5 million in 2022, then increased by 15.14% to $925.1 million in 2023, then gained by 19.39% to $1.1 billion in 2024, then gained by 21.66% to $1.3 billion in 2025, then grew by 6.82% to $1.4 billion in 2026.
  • The last three Total Current Liabilities figures came in at $1.4 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 15.07 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 8.11 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 553.20 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 2.27 Bn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 8.82 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 1.29 Bn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 1.58 Bn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 1.20 Bn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 2.12 Bn
10 Medpace Holdings 17.20 Bn 16.70 Bn 201.64 Mn 1.44 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.44 Bn
Mar 31, 2026 1.35 Bn
Dec 31, 2025 1.34 Bn
Sep 30, 2025 1.28 Bn
Jun 30, 2025 1.22 Bn
Mar 31, 2025 1.12 Bn
Dec 31, 2024 1.10 Bn
Sep 30, 2024 1.04 Bn
Jun 30, 2024 993.09 Mn
Mar 31, 2024 956.65 Mn
Dec 31, 2023 925.13 Mn
Sep 30, 2023 848.52 Mn
Jun 30, 2023 852.44 Mn
Mar 31, 2023 881.89 Mn
Dec 31, 2022 803.47 Mn
Sep 30, 2022 820.87 Mn
Jun 30, 2022 878.96 Mn
Mar 31, 2022 579.43 Mn
Dec 31, 2021 557.22 Mn
Sep 30, 2021 517.18 Mn